Cereno Scientific AB
4 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| CS1 Added to Standard of Care Therapy for Pulmonary Arterial Hypertension (NCT07761572) | Cereno Scientific AB | 2026-09-15 |
| Effect of CS1 in Subjects With Pulmonary Arterial Hypertension (NCT05224531) | Cereno Scientific AB | 2022-05-05 |
| Study Investigation Pharmacokinetics and Pharmacodynamics of CS1 (NCT03903302) | Cereno Scientific AB | 2017-10-06 |
Track Cereno Scientific AB automatically
Every clearance here is in the API, with alerts when new ones post.